Last updated: 20 June 2022 at 4:41pm EST

Henry Ward Wolff Net Worth




The estimated Net Worth of Henry Ward Wolff is at least $2.51 Milhão dollars as of 12 March 2019. Henry Wolff owns over 5,000 units of Sunesis Pharmaceuticals Inc stock worth over $83,875 and over the last 18 years Henry sold SNSS stock worth over $2,422,650.

Henry Wolff SNSS stock SEC Form 4 insiders trading

Henry has made over 35 trades of the Sunesis Pharmaceuticals Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Henry exercised 2,000 units of SNSS stock worth $55,100 on 3 June 2019.

The largest trade Henry's ever made was exercising 37,500 units of Sunesis Pharmaceuticals Inc stock on 11 December 2014 worth over $199,500. On average, Henry trades about 4,494 units every 38 days since 2006. As of 12 March 2019 Henry still owns at least 15,766 units of Sunesis Pharmaceuticals Inc stock.

You can see the complete history of Henry Wolff stock trades at the bottom of the page.



What's Henry Wolff's mailing address?

Henry's mailing address filed with the SEC is C/O CALITHERA BIOSCIENCES, INC., 343 OYSTER POINT BLVD. #200, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Sunesis Pharmaceuticals Inc

Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over $89,557,714 worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth $84,730,221 . The most active insiders traders include Forest Baskett, Scott D Sandell, ePeter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of $14,060,191. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth $1,980.

Complete history of Henry Wolff stock trades at Calithera Biosciences Inc, Portola Pharmaceuticals, Sangamo Therapeutics Inc, eSunesis Pharmaceuticals Inc

Acionista maioritário
Trans.
Transação
Preço total
Henry Ward Wolff
Diretor
Exercício de opção $55,100
3 Jun 2019
Henry Ward Wolff
Diretor
Exercício de opção $25,500
12 Mar 2019
Henry Ward Wolff
Diretor
Exercício de opção $63,600
15 Dec 2017
Henry Ward Wolff
Diretor
Exercício de opção $63,600
5 Oct 2017
Henry Ward Wolff
Diretor
Venda $120,000
10 Jul 2015
Henry Ward Wolff
Diretor
Venda $146,520
10 Jun 2015
Henry Ward Wolff
Diretor
Venda $159,000
11 May 2015
Henry Ward Wolff
Diretor
Venda $183,720
10 Apr 2015
Henry Ward Wolff
Diretor
Exercício de opção $142,700
19 Mar 2015
Henry Ward Wolff
Diretor
Venda $200,160
10 Mar 2015
Henry Ward Wolff
Diretor
Exercício de opção $142,700
4 Mar 2015
Henry Ward Wolff
Diretor
Venda $151,800
10 Feb 2015
Henry Ward Wolff
Diretor
Venda $190,440
12 Jan 2015
Henry Ward Wolff
Diretor
Exercício de opção $527,625
11 Dec 2014
Henry Ward Wolff
Diretor
Venda $22,740
10 Nov 2014
Henry Ward Wolff
Diretor
Venda $20,200
10 Oct 2014
Henry Ward Wolff
Diretor
Venda $24,620
10 Sep 2014
Henry Ward Wolff
Diretor
Venda $141,700
11 Aug 2014
Henry Ward Wolff
Diretor
Venda $198,900
10 Jul 2014
Henry Ward Wolff
Diretor
Venda $234,300
10 Jun 2014
Henry Ward Wolff
Diretor
Venda $192,750
12 May 2014
Henry Ward Wolff
Diretor
Venda $235,800
10 Apr 2014
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Mar 2014
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Feb 2014
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Jan 2014
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Dec 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
13 Nov 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Oct 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
10 Sep 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
13 Aug 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
17 Jul 2013
Henry Ward Wolff
Diretor
Venda $100,000
10 Apr 2013
Henry Ward Wolff
Diretor
Exercício de opção $34,500
28 Feb 2013
Henry Ward Wolff
Diretor
Venda $100,000
23 Jan 2013
Henry Ward Wolff
Diretor
Comprar $27,000
30 Aug 2010


Sunesis Pharmaceuticals Inc executives and stock owners

Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: